The 15-Lipoxygenase-1 Product 13-S-Hydroxyoctadecadienoic Acid Down-Regulates PPAR-δ to Induce Apoptosis in Colorectal Cancer Cells
Diminished apoptosis, a critical event in tumorigenesis, is linked to down-regulated 15-lipoxygenase-1 (15-LOX-1) expression in colorectal cancer cells. 13-S-hydroxyoctadecadienoic acid (13-S-HODE), which is the primary product of 15-LOX-1 metabolism of linoleic acid, restores apoptosis. Nonsteroida...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 100; no. 17; pp. 9968 - 9973 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
19.08.2003
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Diminished apoptosis, a critical event in tumorigenesis, is linked to down-regulated 15-lipoxygenase-1 (15-LOX-1) expression in colorectal cancer cells. 13-S-hydroxyoctadecadienoic acid (13-S-HODE), which is the primary product of 15-LOX-1 metabolism of linoleic acid, restores apoptosis. Nonsteroidal antiinflammatory drugs (NSAIDs) transcriptionally up-regulate 15-LOX-1 expression to induce apoptosis. Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors for linoleic and arachidonic acid metabolites. PPAR-δ promotes colonic tumorigenesis. NSAIDs suppress PPAR-δ activity in colon cancer cells. The mechanistic relationship between 15-LOX-1 and PPAR-δ was previously unknown. Our current study shows that (i) 13-S-HODE binds to PPAR-δ, decreases PPAR-δ activation, and down-regulates PPAR-α expression in colorectal cancer cells; (ii) the induction of 15-LOX-1 expression is a critical step in NSAID down-regulation of PPAR-δ and the resultant induction of apoptosis; and (iii) PPAR-δ is an important signaling receptor for 13-S-HODE-induced apoptosis. The in vivo relevance of these mechanistic findings was demonstrated in our tumorigenesis studies in nude mouse xenograft models. Our findings indicate that the down-regulation of PPARδ by 15-LOX-1 through 13-S-HODE is an apoptotic signaling pathway that is activated by NSAIDs. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 This paper was submitted directly (Track II) to the PNAS office. Abbreviations: 13-S-HODE, 13-S-hydroxyoctadecadienoic acid; 15-LOX-1, 15-lipoxygenase-1; AS, antisense; β-gal, β-galactosidase; COX, cyclooxygenase; E-RKO, pcDNA3.1 empty-vector-transfected RKO cells; LBD, ligand-binding domain; NSAIDs, nonsteroidal antiinflammatory drugs; PPARs, peroxisome proliferator-activated receptors; TUNEL, terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling; W-RKO, WT RKO cells. To whom correspondence should be addressed. E-mail: ishureiqi@mdanderson.org. Edited by Bert Vogelstein, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, and approved June 11, 2003 |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1631086100 |